CID 6478902

Schembl7487904

Structural Information

Molecular Formula
C32H51N5OS
SMILES
CCCCCCCC/C=C/CCCCCCCC(=O)NC1=NN=C(S1)NC2CCN(CC2)CC3=CC=CC=C3
InChI
InChI=1S/C32H51N5OS/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-30(38)34-32-36-35-31(39-32)33-29-23-25-37(26-24-29)27-28-20-17-16-18-21-28/h9-10,16-18,20-21,29H,2-8,11-15,19,22-27H2,1H3,(H,33,35)(H,34,36,38)/b10-9+
InChIKey
VPKPDDQAEUHZAN-MDZDMXLPSA-N
Compound name
(E)-N-[5-[(1-benzylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]octadec-9-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

4
Patents

553.3814 Da
Monoisotopic Mass

9.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 554.38868 237.0
[M+Na]+ 576.37062 234.5
[M-H]- 552.37412 239.1
[M+NH4]+ 571.41522 238.7
[M+K]+ 592.34456 225.6
[M+H-H2O]+ 536.37866 224.0
[M+HCOO]- 598.37960 246.2
[M+CH3COO]- 612.39525 254.9
[M+Na-2H]- 574.35607 230.3
[M]+ 553.38085 238.6
[M]- 553.38195 238.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe